EDMOND, OK
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN DRUG UTILIZATION REVIEW SOCIETY, founded in 2001, is a small nonprofit in the Community Improvement sector that reported $282K in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion.
THE MISSION OF AMERICAN DRUG UTILIZATION REVIEW SOCIETY (ADURS) IS TO PROVIDE A FORUM OF LEADERSHIP AND SUPPORT FOR THE MEMBERSHIP TO OBTAIN INFORMATION, DEVELOP SKILLS AND RECEIVE TRAINING TO EFFICIENTLY AND EFFECTIVELY PERFORM THEIR DUTIES RELATED TO DRUG UTILIZATION REVIEW.
EACH YEAR, A SYMPOSIUM IS ORGANIZED BY AMERICAN DRUG UTILIZATION REVIEW SOCIETY (ADURS) TO PROVIDE UPDATES FOR STATE MEDICAID PROGRAMS WHERE MEMBERS SHARE INFORMATION, DEVELOP SKILLS AND OBTAIN...
EACH YEAR, A SYMPOSIUM IS ORGANIZED BY AMERICAN DRUG UTILIZATION REVIEW SOCIETY (ADURS) TO PROVIDE UPDATES FOR STATE MEDICAID PROGRAMS WHERE MEMBERS SHARE INFORMATION, DEVELOP SKILLS AND OBTAIN TRAINING. THE SYMPOSIUM AVERAGES AROUND 120 INDIVIDUALS REPRESENTING AN AVERAGE OF 43 STATE MEDICAID PROGRAMS. ATTENDEES EARN ACPE APPROVED CONTINUING EDUCATION CREDITS UPON COMPLETION OF THE SYMPOSIUM.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $282,430 | $258,062 | +0.1% |
| Expenses | $299,542 | $232,870 | +0.3% |
| Net Income | $-17,112 | $25,192 | -1.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| TERRY COTHRAN | PROGRAM COMM | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| AMANDA KIRIAKOPOULOS | DIRECTOR AT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| AIMEE LEWIS | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| PAMELA SMITH | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHELLIE KEAST | EXECUTIVE DI | 5.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $282,430 | $299,542 | $553,932 | $-17,112 |
| 2024 | $258,062 | $232,870 | $574,704 | $25,192 |
| 2023 | $237,818 | $346,779 | $522,688 | $-108,961 |
| 2022 | $250,239 | $230,138 | $647,744 | $20,101 |
| 2021 | $71,209 | $108,672 | $693,114 | $-37,463 |
| 2020 | $238,249 | $205,264 | $626,060 | $32,985 |
| 2019 | $238,192 | $225,757 | $635,765 | $12,435 |
Compare AMERICAN DRUG UTILIZATION REVIEW SOCIETY with other nonprofits in Oklahoma and across the country.